Command Palette

Search for a command to run...

Clinical Trials · NCT01093729

A Study of HM11260C in Healthy Male Subject

CompletedPhase 1Exenatide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Hanmi Pharmaceutical Company Limited
Enrollment
41
Start date
Feb 2010
Locations
See registry
Primary endpoint
Safety
View Exenatide compound reference